Weight loss: Gelesis, $22m in hand, registers $60m IPO

Gelesis files for a $60 million initial public offering just a week after raising $22 million.

Gelesis just last week drummed up a $22 million funding round, but that's not stopping the Boston-based company from registering for an initial public offering worth $60 million.

Gelesis Inc.

News Well, Bariatrics, Funding Roundup, Initial Public Offering (IPO), Weight loss

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1anYIc3